| Study of E7389 Liposomal Formulation in Participants With Solid Tumor (NCT03207672) | Eisai Co., Ltd. | 2017-08-18 |
| Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma (NCT03168438) | GlaxoSmithKline | 2017-08-18 |
| Acute Study to Evaluate a Novel Implantable Midfield Powered Device in Humans With Urinary Incontinence (NCT03643380) | Neuspera Medical, Inc. | 2017-08-17 |
| DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis (NCT03305471) | Daiichi Sankyo | 2017-08-17 |
| Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis (NCT03231033) | Children's Hospital Medical Center, Cincinnati | 2017-08-17 |
| An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer (NCT03505528) | EpiAxis Therapeutics | 2017-08-17 |
| Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies (NCT03166215) | Takeda | 2017-08-17 |
| Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease Patients (NCT03255512) | Bayer | 2017-08-17 |
| Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (NCT02819804) | Northwestern University | 2017-08-17 |
| A Phase I Study of AL8326 in Advanced Solid Tumor (NCT04890587) | Advenchen Laboratories Nanjing Ltd. | 2017-08-17 |
| Study of bb21217 in Multiple Myeloma (NCT03274219) | 2seventy bio | 2017-08-16 |
| Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male Subjects (NCT03252002) | Bayer | 2017-08-16 |
| Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers (NCT03236493) | Pfizer | 2017-08-16 |
| CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL. (NCT03263208) | Henan Cancer Hospital | 2017-08-16 |
| Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites (NCT03258372) | Corcept Therapeutics | 2017-08-16 |
| Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors (NCT02756845) | Amgen | 2017-08-16 |
| BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer (NCT03386955) | Beta Pharma Shanghai | 2017-08-16 |
| Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593) (NCT02460874) | University of Alabama at Birmingham | 2017-08-16 |
| Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function. (NCT03212131) | Novo Nordisk A/S | 2017-08-16 |
| A Phase 1 Safety and PK Study of IV TP-271 (NCT03234738) | Tetraphase Pharmaceuticals, Inc | 2017-08-16 |
| Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001) (NCT03170544) | Merck Sharp & Dohme LLC | 2017-08-16 |
| A Study of Lasmiditan in Participants With Migraine (NCT03247790) | Eli Lilly and Company | 2017-08-16 |
| Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI) (NCT03238482) | Orion Corporation, Orion Pharma | 2017-08-16 |
| Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies (NCT03323398) | ModernaTX, Inc. | 2017-08-15 |
| Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors (NCT02975882) | Children's Oncology Group | 2017-08-15 |
| Treatment of Spinal Cord Injuries With (AutoBM-MSCs)vs (WJ-MSCs). (NCT04288934) | University of Jordan | 2017-08-15 |
| A Study of Multiple Doses of Lasmiditan in Healthy Participants (NCT03252015) | Eli Lilly and Company | 2017-08-15 |
| Hyaluronic Acid Hydro-dissection Use in Idiopathic Carpal Tunnel Syndrome Guided by Ultrasonic Study (NCT03180125) | Assiut University | 2017-08-15 |
| A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China (NCT04162275) | Yiling Pharmaceutical Inc. | 2017-08-15 |
| Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD (NCT03103750) | Yale University | 2017-08-15 |
| Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM) (NCT03182426) | University of Alberta | 2017-08-15 |
| Study of Allogeneic Double Negative T Cells (DNT-UHN-1) in Patients With High Risk Acute Myeloid Leukemia (NCT03027102) | University Health Network, Toronto | 2017-08-15 |
| Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors (NCT03252938) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2017-08-15 |
| A Study of BMS-986195 in Healthy Male Subjects (NCT03245515) | Bristol-Myers Squibb | 2017-08-15 |
| Hookah Smoking, Carbon Monoxide, and Coronary Endothelial Function (NCT03166787) | Cedars-Sinai Medical Center | 2017-08-15 |
| Feasibility Study on LITT for Newly Diagnosed Glioblastoma (NCT02880410) | Monteris Medical | 2017-08-15 |
| Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma (NCT03035331) | Mayo Clinic | 2017-08-15 |
| Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects (NCT03235076) | Bayer | 2017-08-15 |
| Niclosamide With Etanercept in Rheumatoid Arthritis (NCT03160001) | Faiq Gorial | 2017-08-15 |
| A Trial of a Single Delivery of SB-061 in Osteoarthritis of the Knee (NCT03231280) | Symic OA Co. | 2017-08-14 |
| Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis (NCT03156023) | Amgen | 2017-08-14 |
| A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants (NCT03232983) | Eli Lilly and Company | 2017-08-14 |
| Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors (NCT03313778) | ModernaTX, Inc. | 2017-08-14 |
| A Study to Investigate the Absorption, Metabolism, Excretion, and Mass Balance of GC4419 in Healthy Adult Subjects (NCT03163173) | Galera Therapeutics, Inc. | 2017-08-14 |
| A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects (NCT03787004) | Centrexion Therapeutics | 2017-08-14 |
| A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants (NCT03249402) | Janssen-Cilag International NV | 2017-08-14 |
| A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers (NCT03250052) | Boryung Pharmaceutical Co., Ltd | 2017-08-14 |
| Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men (NCT02072252) | Northwestern University | 2017-08-14 |
| A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole (NCT03314298) | Havah Therapeutics Pty Ltd | 2017-08-14 |
| Safety of PDT-Photofrin® Prior to Lung Surgery (NCT03344861) | Concordia Laboratories Inc. | 2017-08-14 |
| Dose Escalation Study of Cu(II)ATSM in Parkinson's Disease (NCT03204929) | Collaborative Medicinal Development Pty Limited | 2017-08-14 |
| Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence. (NCT03272425) | Ardea Biosciences, Inc. | 2017-08-14 |
| Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers (NCT03259607) | McNeil AB | 2017-08-14 |
| Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT03282617) | National University Hospital, Singapore | 2017-08-14 |
| A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP) (NCT03275454) | Bioverativ, a Sanofi company | 2017-08-14 |
| Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy (NCT03154645) | Grant S Lipman | 2017-08-12 |
| Percutaneous Ethanol Injection for Benign Cystic Thyroid Nodules (NCT03257930) | hassan harby mohamed | 2017-08-11 |
| Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS) (NCT03109288) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-08-11 |
| A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose (NCT03250182) | Pearl Therapeutics, Inc. | 2017-08-11 |
| QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy (NCT03136406) | ImmunityBio, Inc. | 2017-08-11 |
| Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection (NCT03202992) | Antiva Biosciences | 2017-08-11 |
| Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects (NCT03306589) | GlaxoSmithKline | 2017-08-11 |
| A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma (NCT03242889) | Janssen Pharmaceutical K.K. | 2017-08-10 |
| This Study Tests How Healthy Men Tolerate Different Doses of BI1015550. The Study Also Tests How BI 1015550 is Taken up by the Body (NCT03230487) | Boehringer Ingelheim | 2017-08-10 |
| Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Healthy Adult Volunteers (NCT03245918) | The Hospital for Sick Children | 2017-08-10 |
| A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood) (NCT03245229) | Idorsia Pharmaceuticals Ltd. | 2017-08-10 |
| An Open Study to Assess the Safety and Pharmacokinetics of Fluorothyazinone as a Single-Dose Administration or a Treatment Course in Healthy Volunteers (NCT03205462) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2017-08-10 |
| Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT03125239) | Jacqueline Garcia, MD | 2017-08-10 |
| Pembrolizumab + CVA21 in Advanced NSCLC (NCT02824965) | Olivia Newton-John Cancer Research Institute | 2017-08-09 |
| Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors (NCT02723864) | National Cancer Institute (NCI) | 2017-08-09 |
| Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant (NCT03192397) | Roswell Park Cancer Institute | 2017-08-09 |
| Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor (NCT03259542) | Corcept Therapeutics | 2017-08-09 |
| Bioequivalence Trial of Concor AM® vs Bisoprolol and Amlodipine in Chinese Participants (NCT03226275) | Merck KGaA, Darmstadt, Germany | 2017-08-09 |
| Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer (NCT03114462) | M.D. Anderson Cancer Center | 2017-08-09 |
| Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin (NCT03250598) | Agios Pharmaceuticals, Inc. | 2017-08-09 |
| Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART (NCT03198559) | University of Melbourne | 2017-08-08 |
| Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China (NCT03288636) | Ascletis Pharmaceuticals Co., Ltd. | 2017-08-08 |
| Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors (NCT03015324) | Peng Wang, MD PhD | 2017-08-08 |
| Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid Tumors (NCT03243643) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2017-08-08 |
| A Study of HMPL-689 in Patients With Lymphomas Failed of Standard of Care or no Standard of Care Existed (NCT03128164) | Hutchison Medipharma Limited | 2017-08-08 |
| Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors (NCT03250832) | Tesaro, Inc. | 2017-08-08 |
| A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors (NCT03184870) | Bristol-Myers Squibb | 2017-08-08 |
| A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of Cytisine (NCT03268343) | Achieve Life Sciences | 2017-08-08 |
| M8891 First in Human in Solid Tumors (NCT03138538) | EMD Serono Research & Development Institute, Inc. | 2017-08-08 |
| Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma (NCT03177668) | Kissei Pharmaceutical Co., Ltd. | 2017-08-08 |
| Post-Stroke Improvement of Motor Function (NCT03543917) | Fundatia Bio-Forum | 2017-08-08 |
| First-in-human Study to Investigate Safety, Blood Levels and Activity of MP0274 in Cancer Patients With HER2-positive Solid Tumors (NCT03084926) | Molecular Partners AG | 2017-08-08 |
| OMO-1 in Solid Malignancies (NCT03138083) | Octimet Oncology N.V. | 2017-08-08 |
| Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea (NCT03524963) | Bundang CHA Hospital | 2017-08-07 |
| Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases (NCT03310008) | Celyad Oncology SA | 2017-08-07 |
| Assessment of Anti-RANKL Antibody in Post-menopausal Women (NCT03242512) | Jiangsu T-Mab Biopharma Co.,Ltd | 2017-08-07 |
| A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers (NCT02919696) | Eli Lilly and Company | 2017-08-07 |
| A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets (NCT03225352) | Bayer | 2017-08-07 |
| Safety, Tolerability, PK, Dosimetry, MTD and Preliminary Efficacy of Intra-lesionally Injected AvidinOX, Followed by IV Escalating Doses of [177Lu]DOTA-biotin in Pts With Injectable Solid Tumors or Lymphomas (NCT03188328) | Alfasigma S.p.A. | 2017-08-07 |
| A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706 (NCT03235362) | Yuhan Corporation | 2017-08-07 |
| Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Participants (NCT03237741) | Genentech, Inc. | 2017-08-07 |
| To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin (NCT03247673) | Celltrion | 2017-08-07 |
| Traumatic Brain Injury and Effects of Acute Cyclosporine A (NCT02496975) | Edward Hall,PhD | 2017-08-07 |
| Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants (NCT03237156) | Takeda | 2017-08-07 |
| A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers (NCT03827629) | INSYS Therapeutics Inc | 2017-08-07 |